About Us
Markets
Research
Services
NRI Corner
Fund Transfer
Select Link
MF Back Office-SB
MF Back Office-Client
Back Office - Client
Back Office - Sub Brokers
Backoffice – Family Login
Webmail
SPEEDe Login
BSE STAR MF
Branch Login
Create Account
About Us
Markets
Research
Services
Portfolio
NRI Cornor
Fund Transfer
Company Snapshot
Read it, Learn it and Do it for your investment Needs
Equity
Derivatives
Currency
Mutual Fund
IPO
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Daily market Tracker
Daily market Tracker
Market Analysis
News Analysis
Company profile
Corporate Actions
Other Market
ETF market Watch
Home > Market > Equity >
Company Snapshot
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Technicals
+12 more
Score Board
Directors Report
MF Holding
Charts
Company News
History
Monthly High Low
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Deliverable Volumes
Share Holdings Pattern
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company Profile
Get Quotes
Company Snapshot
Company Background
Board Of Directors
Peer Comparison
Balance Sheet
Profit & Loss
Quarterly Results
Key Financial Ratios
Share Holdings Pattern
Charts
Company News
Directors Report
History
MF Holdings
Profit & Loss
Monthly High Low
Technicals
Deliverable Volumes
Bonus Issue
Demergers
Dividend
Mergers
Right Issues
Split Of Facevalue
Company Snapshot
Beta Drugs Ltd
Pharmaceuticals - Indian - Bulk Drugs
BSE Code:
535022
NSE Symbol:
BETA
P/E :
125.26
ISIN Demat:
INE351Y01019
Div & Yield %:
0
EPS :
14.14
Book Value:
147.54
Market Cap (Rs. Cr.):
1,795.45
Face Value :
10
Exchange
BSE
NSE
Stock Price Details
Last Price (₹)
Change
Best Buy (₹)
Best Sell (₹)
Today's Range
-
52-Week Range
-
Beta (1 Year)
Chart
1 Day
|
5 Day
|
3 Month
|
1 Year
|
5 Year
Index Details
Corporate Announcements
Beta Drugs consolidated net profit rises 0.22% in the March 2026 quarter>
Beta Drugs to conduct board meeting>
Beta Drugs consolidated net profit declines 4.80% in the December 2025 quarter>
Beta Drugs schedules EGM>
Beta Drugs to conduct board meeting>
Corporate Details
Incorporation Year :
2005
Chairman :
Rahul Batra
Ownership Group :
Indian Private
Sector :
Pharmaceuticals
Industry :
Pharmaceuticals - Indian - Bulk Drugs
Registered Office :
Beta Drugs Ltd
Village Nandpur,
,
Baddi,
Himachal Pradesh - 174101,
Phone : 91-1795-236196,
Fax : N.A.
E-Mail :
info@betadrugslimited.com
URL :
http://www.betadrugslimited.com
Investor Returns
Period
Date
Price(
₹
)
Returns (%)
1Week
1Month
3Month
6Month
1Year
No Data Found
Mutual Funds Holding
Scheme Name
% Holding
Market Value (₹.Cr)
No Data Found
Peer Groups : Pharmaceuticals - Indian - Bulk Drugs
Company
Last Price(
₹
)
Change(%)
52Week High(
₹
)
52Week Low(
₹
)
Market Cap(
₹
)
Divis Laboratories Ltd
6,633.05
-0.27
7,077.70
5,637.50
176,086.64
Acutaas Chemicals Ltd
3,146.45
0.56
3,442.40
1,059.05
25,760.34
Neuland Laboratories Ltd
17,177.50
1.33
19,748.40
11,500.00
22,038.54
Jubilant Pharmova Ltd
975.30
3.10
1,250.00
783.75
15,536.53
Gujarat Themis Biosyn Ltd
387.65
1.48
479.45
225.75
4,224.04